ABN AMRO Bank N.V. Cuts Stake in Synopsys, Inc. $SNPS

ABN AMRO Bank N.V. cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 82.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,342 shares of the semiconductor company’s stock after selling 24,615 shares during the quarter. ABN AMRO Bank N.V.’s holdings in Synopsys were worth $2,128,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the stock. Sankala Group LLC bought a new stake in shares of Synopsys during the fourth quarter valued at approximately $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Synopsys during the fourth quarter valued at $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the fourth quarter valued at $28,000. Atlas Capital Advisors Inc. bought a new position in Synopsys during the 4th quarter valued at about $32,000. Finally, Phillip James Consulting Co. purchased a new stake in shares of Synopsys during the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.

Synopsys Price Performance

Shares of SNPS stock opened at $454.34 on Monday. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The company has a market capitalization of $87.00 billion, a price-to-earnings ratio of 105.17, a PEG ratio of 2.67 and a beta of 1.22. The company’s fifty day moving average price is $483.67 and its 200-day moving average price is $462.12.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s revenue was up 41.9% on a year-over-year basis. During the same period in the previous year, the business earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SNPS has been the subject of a number of research analyst reports. Morgan Stanley lifted their price target on shares of Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Bank of America increased their target price on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Citigroup raised their target price on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Robert W. Baird set a $558.00 price target on Synopsys in a research note on Thursday, May 28th. Finally, Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their price target for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $570.06.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.